QIAGEN and Max Planck Institute for Infection Biology Collaborate to Develop Assay for Active TB Risk in Individuals With Latent... (ed testing customers for purposes such a...)

HOME >> BIOLOGY >> TECHNOLOGY

QIAGEN and Max Planck Institute for Infection Biology Collaborate to Develop Assay for Active TB Risk in Individuals With Latent Infection

Date:1/9/2012

ed testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN's assay technologies include one of the broadest panels of molecular diagnostic tests available worldwide. This panel includes the first FDA-approved test for human papillomavirus (HPV), the primary cause of cervical cancer, as well as a broad suite of solutions for infectious disease testing and companion diagnostics. As of September 30, 2011, QIAGEN employed approximately 3,800 people in over 35 locations worldwide. Further information about QIAGEN can be found at http://www.qiagen.com/.

Certain of the statements contained in this news release may be considered forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. To the extent that any of the statements contained herein relating to QIAGEN's products, markets, strategy or operating results, including without limitation its expected operating results, are forward-looking, such statements are based on current expectations and assumptions that involve a number of uncertainties and risks. Such uncertainties and risks include, but are not limited to, risks associated with management of growth and international operations (including the effects of currency fluctuations, regulatory processes and dependence on logistics), variability of operating results and allocations between customer classes, the commercial development of markets for our products in applied testing, personalized healthcare, clinical research, proteomics, women's health/HPV testing and nucleic acid-based molecular diagnostics; changing relationships with customers, suppliers and strategic partners; competition; rapid or unexpected changes in technologies; fluctuations in demand for QIAGEN's products (including fluctuations due to general economic conditions, the level
'/>"/>

SOURCE QIAGEN N.V.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7
Related biology technology :

1. QIAGEN to Develop New Companion Diagnostic for Compound in Clinical Trials for Blood Cancers
2. QIAGEN and Abbott Enter Into Agreement on Molecular Tests for HIV, HCV and HPV
3. QIAGEN and Roche Settle Dispute Over Distribution Agreement for TheraScreen Companion Diagnostics
4. QIAGEN Acquires Comprehensive Portfolio of Molecular Food Safety Tests
5. QIAGEN Acquires Exclusive Licence for Key PI3K gene
6. QIAGENs New Product Line, QIAsafe(R) DNA Blood, has Been Co-Developed With Biomatrica and is Based on Biomatricas SampleMatrix(R) Technology
7. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) Second Quarter 2009 Financial Results Call Set for August 11
8. Plexus Awarded Development Contract With QIAGEN
9. QIAGEN and Chittaranjan National Cancer Institute Partner to Establish First Large-Scale Cervical Cancer Screening Program in Kolkata
10. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) Fourth Quarter and Year-End 2008 Financial Results Call Set for February 10
11. QIAGEN Welcomes 3,000th Employee in 20th year of U.S. Operations

Post Your Comments:

(Date:5/16/2013)... 16, 2013 ISPE ... Myers, CAE, to the newly created position of ... role, Myers will be responsible for stimulating ISPE’s ... strategies, advancing the Society’s Member-led and staff-driven business ... to refine organizational, membership and product marketing. , ...

(Date:5/16/2013)... (PRWEB) May 16, 2013 In late 2012, ... to speak to doctors in China about Appearance Medicine ... NZ, this was her first trip to lecture in China, ... visited Guangzhou and Fuzhou, home to 12 and 7 million ... is very high at this point in time. As Dr. ...

(Date:5/16/2013)... Cambridge Healthtech Institute will host its fifth annual ... Renaissance Waterfront Hotel in Boston, MA. The ten ... the current strategies and innovations for optimizing bioprocesses while ... the field will reveal how their work has resulted ... and efficiency. , “In this age of rapid innovation, ...

(Date:5/16/2013)... , May 16, 2013 HealthSparq, a trusted ... the nation,s largest regional health plans, will debut ... Insurance Plans (AHIP) Institute 2013 conference on June ... results showing how health insurance companies across the ... consumer and marketplace demands for increased healthcare transparency. ...

Breaking Biology Technology:ISPE Names Barbara A. Myers, CAE, as Vice President of Professional Development 2 The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA 2 HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 2 HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 3

[0] ISPE Names Barbara A. Myers, CAE, as Vice President of Professional Development [0] Palm Clinic New Zealand Doctor Trains Chinese Doctors at International Micro-Plastic Annual Exchange Conference [0] The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA [0] HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013

... 31 Schering-Plough,Corporation (NYSE: SGP ) today ... has accepted the Peg-IFN (peginterferon alfa-2b),supplemental Biologics License ... status for the adjuvant treatment of patients with,Stage ... agency,in the fall of 2007., The Priority ...

... Jan. 31 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ... webcast live during the 10th Annual BIO CEO ... 1:15 p.m. Eastern Time., The presentation will ... To access the live presentation via the Web, ...

... and Backlog Increase to Record Highs, BEDFORD, Mass., ... diversified medical technologies company specializing in,diagnostics, imaging systems and ... today announced its results for the,quarter ended December 29, ... -- Record revenues of $371.4 million. -- Merger ...

FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma Alexza's Corporate Presentation to be Webcast at the 10th Annual BIO CEO & Investor Conference Hologic Announces First Quarter Fiscal 2008 Operating Results

(Date:5/16/2013)... adults living closer to a fast food restaurant had ... lived further away from fast food, according to researchers ... and this association was particularly strong among those with ... online in the American Journal of Public Health ... a fast food restaurant, and among lower-income African-Americans, the ...

(Date:5/16/2013)... CAMBRIDGE, MA -- Injectable nanoparticles developed at MIT ... Type 1 diabetes to constantly monitor their blood-sugar ... nanoparticles were designed to sense glucose levels in ... amount of insulin, thereby replacing the function of ... with Type 1 diabetes. Ultimately, this type of ...

(Date:5/16/2013)... do so many sports players and athletes choose to ... study to be published in Psychological Science , ... that it may have to do with their testosterone ... Daniel Farrelly of the University of Sunderland and colleagues, ... in a competitive task had higher testosterone levels than ...

Breaking Biology News(10 mins):Body mass index of low income African-Americans linked to proximity of fast food restaurants 2 Body mass index of low income African-Americans linked to proximity of fast food restaurants 3 Nanotechnology could help fight diabetes 2 Nanotechnology could help fight diabetes 3 High-testosterone competitors more likely to choose red 2

[0] Body mass index of low income African-Americans linked to proximity of fast food restaurants [0] Nanotechnology could help fight diabetes [0] High-testosterone competitors more likely to choose red

... what the doctor orders for individuals suffering from dry eye ... tear film composition. According to a study published in ... 30 degrees Celsius on the eye and eyelid could be ... The study, (Meibomian Lipid Films and the Impact of ...

... How well our brain functions is largely based on ... led study. The study published in the international publication ... of a genetic effect on how ,cost-efficient, our brain network ... up. Lead author Dr Alex Fornito from the Melbourne ...

... the food web each spring in places like the Arctic ... the first published findings about this ability. The same ... antifreeze against temperatures well below minus 10 C is also ... that are hospitable to itself and other microorganisms. Altering ...

Cached Biology News:Drop in temperature may explain the increase in dry eye suffering 2 Better brain wiring linked to family genes 2 Algal antifreeze makes inroads into ice 2

Drop in temperature may explain the increase in dry eye suffering Better brain wiring linked to family genes Algal antifreeze makes inroads into ice

Mouse HAI-1 Ectodomain MAb (Clone 199732)...

pETDuet-1 is designed for the coexpression of two target genes....

Human IL-29/IFN-lambda 1 Biotinylated Affinity Purified PAb...

Mouse Laminin-1 MAb (Clone AL-3)...

Biology Products:

Rat Anti-Mouse HAI-1 Ectodomain Monoclonal Antibody, Unconjugated, Clone 199732 from R&D Systems pETDuet-1 from Novagen Goat Anti-Human IL-29 / IFN-lambda 1 Polyclonal Antibody, Biotin Conjugated from R&D Systems Anti-Mouse Laminin-1 Monoclonal Antibody, Unconjugated, Clone AL-3 from R&D Systems